1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for The Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Glaucoma Therapeutics Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunities

4.1.4.   Challenges

4.2. Technological Landscape

4.3. Regulatory Framework

4.4. Company Market Share Analysis, 2019

4.5. Porter’s Five forces analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Glaucoma Therapeutics Market Overview

5.1. Market Size & Forecast by Value, 2016-2026

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast 2016-2026

5.2.1.   By Disease Indication

5.2.1.1.       Open-Angle Glaucoma

5.2.1.2.       Angle Closure Glaucoma

5.2.1.3.       Others

5.2.2.   By Drug Class

5.2.2.1.       Beta-Blockers

5.2.2.2.       Prostaglandin Analogues

5.2.2.3.       Alpha Adrenergic Agonists

5.2.2.4.       Carbonic Anhydrase Inhibitors

5.2.2.5.       Combination Drugs

5.2.2.6.       Others

5.2.3.   By Distribution Channel

5.2.3.1.       Hospital Pharmacy

5.2.3.2.       Retail Pharmacy

5.2.3.3.       Online Pharmacy

5.2.4.   By Region

5.2.4.1.       North America

5.2.4.2.       Europe

5.2.4.3.       Asia Pacific

5.2.4.4.       Latin America

5.2.4.5.       Middle East & Africa

6.    North America Glaucoma Therapeutics Market

6.1. Market Size & Forecast by Value, 2016-2026

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast 2016-2026

6.2.1.   By Disease Indication

6.2.2.   By Drug Class

6.2.3.   By Distribution Channel

6.2.4.   By Country

6.2.4.1.       U.S

6.2.4.2.       Canada

7.    Europe Glaucoma Therapeutics Market

7.1. Market Size & Forecast by Value, 2016-2026

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast 2016-2026

7.2.1.   By Disease Indication

7.2.2.   By Drug Class

7.2.3.   By Distribution Channel

7.2.4.   By Country

7.2.4.1.       Germany

7.2.4.2.       U.K

7.2.4.3.       France

7.2.4.4.       Italy

7.2.4.5.       Spain

7.2.4.6.       Rest of Europe

8.    Asia Pacific Glaucoma Therapeutics Market

8.1. Market Size & Forecast by Value, 2016-2026

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast 2016-2026

8.2.1.   By Disease Indication

8.2.2.   By Drug Class

8.2.3.   By Distribution Channel

8.2.4.   By Country

8.2.4.1.       China

8.2.4.2.       India

8.2.4.3.       Japan

8.2.4.4.       South Korea

8.2.4.5.       Rest of Asia Pacific

9.    Latin America Glaucoma Therapeutics Market

9.1. Market Size & Forecast by Value, 2016-2026

9.1.1.   By Value (USD Million)

9.2. Market Share & Forecast 2016-2026

9.2.1.   By Disease Indication

9.2.2.   By Drug Class

9.2.3.   By Distribution Channel

9.2.4.   By Country

9.2.4.1.       Brazil

9.2.4.2.       Mexico

9.2.4.3.       Argentina

9.2.4.4.       Rest of Latin America

10.Middle East & Africa Glaucoma Therapeutics Market

10.1.             Market Size & Forecast by Value, 2016-2026

10.1.1.                By Value (USD Million)

10.2.             Market Share & Forecast 2016-2026

10.2.1.                By Disease Indication

10.2.2.                By Drug Class

10.2.3.                By Distribution Channel

10.2.4.                By Country

10.2.4.1.    Saudi Arabia

10.2.4.2.    UAE

10.2.4.3.    South Africa

10.2.4.4.    Rest of Middle East & Africa

11.Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

11.1.             The Linde Group

11.2.             Air Liquide S.A.

11.3.             Illinois Tool Works Inc.

11.4.             Colfax Corporation

11.5.             Lincoln Electric Holdings Inc.

11.6.             Messer Group

11.7.             African Oxygen Limited

11.8.             GCE Holding AB

11.9.             Koike Aronson, Inc.

11.10.          Fronius International GmbH

11.11.          Matheson Tri-Gas, Inc.

11.12.          Bug-O Systems Inc.

11.13.          Gentec (Shanghai) Corporation

11.14.          British Oxygen Company

11.15.          Müller Opladen

11.16.          Cavagna Group

11.17.          Rotarex

11.18.          Other Prominent Players

 

List of Figures:

Fig: Global Glaucoma Therapeutics Segmentation

Fig: Company Market Share Analysis, 2019

Fig: Global Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: Global Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: Global Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: Global Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: Global Glaucoma Therapeutics Market Share, By Region, By Value, 2016-2026

Fig: North America Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: North America Glaucoma Therapeutics Market Y-o-Y Growth, By Value, 2017-2026

Fig: North America Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: North America Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: North America Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: North America Glaucoma Therapeutics Market Share, By Country, By Value, 2016-2026

Fig: Europe Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: Europe Glaucoma Therapeutics Market Y-o-Y Growth, By Value, 2017-2026

Fig: Europe Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: Europe Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: Europe Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: Europe Glaucoma Therapeutics Market Share, By Country, By Value, 2016-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Y-o-Y Growth, By Value, 2017-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: Asia-Pacific Glaucoma Therapeutics Market Share, By Country, By Value, 2016-2026

Fig: Latin America Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: Latin America Glaucoma Therapeutics Market Y-o-Y Growth, By Value, 2017-2026

Fig: Latin America Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: Latin America Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: Latin America Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: Latin America Glaucoma Therapeutics Market Share, By Country, By Value, 2016-2026

Fig: Middle-East & Africa Glaucoma Therapeutics Market Size, By Value (USD Million), 2016-2026

Fig: Middle-East & Africa Glaucoma Therapeutics Market Y-o-Y Growth, By Value, 2017-2026

Fig: Middle East & Africa Glaucoma Therapeutics Market Share, By Disease Indication, By Value, 2016-2026

Fig: Middle East & Africa Glaucoma Therapeutics Market Share, By Drug Class, By Value, 2016-2026

Fig: Middle East & Africa Glaucoma Therapeutics Market Share, By Distribution Channel, By Value, 2016-2026

Fig: Middle East & Africa Glaucoma Therapeutics Market Share, By Country, By Value, 2016-2026

 

List of Tables:

Table: Global Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: Global Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: Global Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: Global Glaucoma Therapeutics Market Size, By Region, By Value, 2016-2026

Table: North America Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: North America Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: North America Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: North America Glaucoma Therapeutics Market Size, By Country, By Value, 2016-2026

Table: Europe Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: Europe Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: Europe Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: Europe Glaucoma Therapeutics Market Size, By Country, By Value, 2016-2026

Table: Asia-Pacific Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: Asia-Pacific Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: Asia-Pacific Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: Asia-Pacific Glaucoma Therapeutics Market Size, By Country, By Value, 2016-2026

Table: Latin America Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: Latin America Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: Latin America Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: Latin America Glaucoma Therapeutics Market Size, By Country, By Value, 2016-2026

Table: Middle East & Africa Glaucoma Therapeutics Market Size, By Disease Indication, By Value, 2016-2026

Table: Middle East & Africa Glaucoma Therapeutics Market Size, By Drug Class, By Value, 2016-2026

Table: Middle East & Africa Glaucoma Therapeutics Market Size, By Distribution Channel, By Value, 2016-2026

Table: Middle East & Africa Glaucoma Therapeutics Market Size, By Country, By Value, 2016-2026

Table: Merck & Co., Inc. Financial Analysis

Table: Novartis AGFinancial Analysis

Table: Allergan plc Financial Analysis

Table: Bausch & Lomb IncorporatedFinancial Analysis

Table: Teva Pharmaceutical IndustryFinancial Analysis

Table: Aerie PharmaceuticalFinancial Analysis

Table: Pfizer Inc.Financial Analysis

Table: Inotek PharmaceuticalsFinancial Analysis

 

*Financial Information of non-listed companies will be provided as per the availability

 

**The segmentation and the companies are subjected to modification based on the in-depth secondary for the final deliverable.